TAKING any dose of common non-steroidal anti-inflammatory drugs (NSAIDs), such as naproxen and ibuprofen, for as little as one week has been linked to an increased risk of heart attack, according to University of Montreal Department of Pharmacy research.
While the link has been known for some time, and highlighted at the time of the delisting of cox-2 inhibitor rofecoxib from MSD, the timing of the risk and the impact of dose had remained a question.
Now the Canadian researchers have demonstrated that the risk of heart attack was greater with higher doses and during the first month of use.
The study found that all NSAIDs, even over-the-counter products such as naproxen, were linked with an increased risk of heart attack.
CLICK HERE to access the study.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 May 17